Trastuzumab Not Yet Recruiting Phase 3 Trials for Breast Cancer Invasive Nos Other

IndicationsStatusPurposePhase
Not Yet RecruitingOther3
clinicaltrials.gov IdentifierTitleDrugs
NCT03595592Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer